Email Updates
Go to Basic Search
Results
Total Results: 597 records
Showing results for "risk".
-
srdr.ahrq.gov/projects/1591/studies/195592January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195574January 01, 2020 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195572January 01, 2020 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195594January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195494January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195549January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1565/studies/188518January 01, 2016 - The trial was expected to have an 80% power to detect a risk reduction in the rate of the composite … of the randomization arm) and an extended follow-up period of ≥2 years and ≤7 years, a significant risk … Cochrane) Comments ( 0 ) | Post/View No confounding risk
-
srdr.ahrq.gov/projects/1705/studies/197179January 01, 2014 - screening strategies (e.g., universal vs. targeted screening or screening strategies based on alternative risk
-
srdr.ahrq.gov/home/indexDecember 13, 2021 - pre-established criteria, studies were selected, dual reviewed, data abstracted, and evaluated for risk … implement to reduce length of stay (LOS), with emphasis on medically complex or vulnerable patients at high-risk
-
srdr.ahrq.gov/December 13, 2021 - pre-established criteria, studies were selected, dual reviewed, data abstracted, and evaluated for risk … implement to reduce length of stay (LOS), with emphasis on medically complex or vulnerable patients at high-risk
-
srdr.ahrq.gov/projects/1520/studies/186754January 01, 2019 - Comments ( 0 ) | Post/View Q6: ROBINS-I - Risk of bias judgement for BIAS DUE TO CONFOUNDING … Comments ( 0 ) | Post/View Q13: ROBINS-I - Risk of bias judgement for BIAS IN SELECTION OF
-
srdr.ahrq.gov/projects/1312/studies/133146January 01, 2014 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … All overweight (BMI 25-32 kg/m^2)- not sure if this counts as increased risk since not all technically
-
srdr.ahrq.gov/projects/1312/studies/133107January 01, 2011 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Comments ( 0 ) | Post/View Adults at an increased risk
-
srdr.ahrq.gov/projects/1312/studies/133211January 01, 2014 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status Adults at an increased risk
-
srdr.ahrq.gov/projects/1591/studies/195519January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195581January 01, 2020 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195546January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1591/studies/195609January 01, 2019 - Which patients in which settings are most at risk of harms?
-
srdr.ahrq.gov/projects/1520/studies/186693January 01, 2019 - suspicion of a colorectal malignancy, OR 4) patients classified with a preoperative or postoperative risk … Comments ( 0 ) | Post/View Q6: ROBINS-I - Risk of bias judgement for BIAS DUE TO CONFOUNDING … Comments ( 0 ) | Post/View Q13: ROBINS-I - Risk of bias judgement for BIAS IN SELECTION OF
-
srdr.ahrq.gov/projects/1312/studies/175426January 01, 2015 - 1 Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … fasting glucose or impaired glucose tolerance and insulin levels ≥5 μIU/mL, plus ≥2 of the following risk
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
